Malgorzata Krajewska
Overview
Explore the profile of Malgorzata Krajewska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pomaville M, Chennakesavalu M, Wang P, Jiang Z, Sun H, Ren P, et al.
Cell Rep
. 2024 May;
43(5):114165.
PMID: 38691450
The N-methyladenosine (mA) RNA modification is an important regulator of gene expression. mA is deposited by a methyltransferase complex that includes methyltransferase-like 3 (METTL3) and methyltransferase-like 14 (METTL14). High levels...
2.
Sengupta S, Das S, Crespo A, Cornel A, Patel A, Mahadevan N, et al.
Nat Cancer
. 2022 Sep;
3(10):1228-1246.
PMID: 36138189
Apart from the anti-GD2 antibody, immunotherapy for neuroblastoma has had limited success due to immune evasion mechanisms, coupled with an incomplete understanding of predictors of response. Here, from bulk and...
3.
Gao Y, Volegova M, Nasholm N, Das S, Kwiatkowski N, Abraham B, et al.
Front Oncol
. 2022 Feb;
11:773186.
PMID: 35198433
Purpose: Cyclin-dependent kinases (CDKs) that have critical roles in RNA polymerase II (Pol II)-mediated gene transcription are emerging as therapeutic targets in cancer. We have previously shown that THZ1, a...
4.
Bayles I, Krajewska M, Pontius W, Saiakhova A, Morrow J, Bartels C, et al.
J Clin Invest
. 2019 Sep;
129(10):4377-4392.
PMID: 31498151
Despite progress in intensification of therapy, outcomes for patients with metastatic osteosarcoma (OS) have not improved in thirty years. We developed a system that enabled preclinical screening of compounds against...
5.
Krajewska M, Dries R, Grassetti A, Dust S, Gao Y, Huang H, et al.
Nat Commun
. 2019 Apr;
10(1):1757.
PMID: 30988284
Cyclin-dependent kinase 12 (CDK12) modulates transcription elongation by phosphorylating the carboxy-terminal domain of RNA polymerase II and selectively affects the expression of genes involved in the DNA damage response (DDR)...
6.
Krajewska M, Fehrmann R, de Vries E, van Vugt M
Front Genet
. 2015 Apr;
6:96.
PMID: 25852742
To cope with DNA damage, cells possess a complex signaling network called the 'DNA damage response', which coordinates cell cycle control with DNA repair. The importance of this network is...
7.
Fehrmann R, Karjalainen J, Krajewska M, Westra H, Maloney D, Simeonov A, et al.
Nat Genet
. 2015 Jan;
47(2):115-25.
PMID: 25581432
Many cancer-associated somatic copy number alterations (SCNAs) are known. Currently, one of the challenges is to identify the molecular downstream effects of these variants. Although several SCNAs are known to...
8.
Heijink A, Krajewska M, van Vugt M
Mutat Res
. 2013 Jul;
750(1-2):45-55.
PMID: 23880065
Cells are equipped with a cell-intrinsic signaling network called the DNA damage response (DDR). This signaling network recognizes DNA lesions and initiates various downstream pathways to coordinate a cell cycle...
9.
10.
Kaluzny J, Szaflik J, Czechowicz-Janicka K, Kaluzny J, Orzalkiewicz A, Zaleska-Zmijewska A, et al.
Klin Oczna
. 2004 Oct;
106(1-2 Suppl):241-2.
PMID: 15510513
Purpose: To establish the efficacy and safety of timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination, each given twice daily, in primary open-angle glaucoma and ocular hypertensive...